Myelosuppressive agents are drugs that suppress bone marrow activity, leading to a reduction in the production of blood cells. These agents are commonly used in the treatment of various types of cancer, particularly in chemotherapy. The bone marrow suppression can affect the production of red blood cells, white blood cells, and platelets, making patients more susceptible to anemia, infections, and bleeding complications.
